Inflammation: Good or bad for ADHD?

ADHD Attention Deficit and Hyperactivity Disorders

Volumn 2, Issue 4, 2010, Pages 257-266

  Donev, Rossen ^a   Thome, Johannes ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Adhd; Apoptosis; Cytokines; Inflammation; Neurodegeneration; Neurogenesis

Indexed keywords

ALCOHOL; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CILIARY NEUROTROPHIC FACTOR RECEPTOR; COMPLEMENT COMPONENT C5A; ESSENTIAL FATTY ACID; FOOD ADDITIVE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTROPHIN 3; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROTEIN KINASE;

ALCOHOL CONSUMPTION; ATOPIC DERMATITIS; ATTENTION DEFICIT DISORDER; BRAIN INJURY; DEVELOPMENTAL GENE; ENVIRONMENTAL FACTOR; GENETIC RISK; HUMAN; IMMUNE RESPONSE GENE; INFLAMMATION; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DERMATITIS, ATOPIC; ENCEPHALITIS; ETHANOL; FATTY ACIDS, OMEGA-3; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; PROTEIN KINASES; RISK FACTORS; SIGNAL TRANSDUCTION; SMOKING;

EID: 79960071166     PISSN: 18666116     EISSN: 18666647     Source Type: Journal    
DOI: 10.1007/s12402-010-0038-7     Document Type: Review

References (109)

1. Aerts N, De Knop K, Leysen J, Ebo D, Bridts C, Weyler J, Stevens W, De Clerck L (2010) Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology (in press)
2. Asghar S, Pasch M (2000) Therapeutic inhibition of the complement system. Y2K update. Front Biosci 5:E63-E81
3. Atkins C, Oliva AJ, Alonso O, Pearse D, Bramlett H, Dietrich W (2007) Modulation of the cAMP signaling pathway after traumatic brain injury. Exp Neurol 208:145-158
4. Barbacid M, Lamballe F, Pulido D, Klein R (1991) The trk family of tyrosine protein kinase receptors. Biochim Biophys Acta 1072:115-127
5. Barnum S (1995) Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 6:132-146
6. Bazan N (2006) Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 29:263-271
7. Bergamaschi A, Corsi M, Garnier M (2006) Synergistic effects of cAMP-dependent signalling pathways and IL-1 on IL-6 production by H19-7/IGF-IR neuronal cells. Cell Signal 18:1679-1684
8. Bhat N, Zhang P, Lee J, Hogan E (1998) Extracellular signalregulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633-1641
9. Bonci A, Williams J (1997) Increased probability of GABA release during withdrawal from morphine. J Neurosci 17:796-803
10. Bradstreet J, Smith S, Baral M, Rossignol D (2010) Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. Altern Med Rev 15:15-32
11. Chalon S (2006) Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75:259-269
12. Choi S, Joe E, Kim S, Jin B (2003) Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci 23:5877-5886
13. Church DF, Pryor WA (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64:111-126
14. Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141-1151
15. Combs C, Karlo J, Kao S, Landreth G (2001) Beta-Amyloid stimulation of microglia and monocytes results in TNFalphadependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179-1188
16. Conner A, Kissling C, Hodges E, Hünnerkopf R, Clement R, Dudley E, Freitag C, Rösler M, Retz W, Thome J (2008) Neurotrophic factor-related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high-risk male population. Am J Med Genet B Neuropsychiatr Genet 147B: 1476-1480
17. Conrad C, Marshall P, Talent J, Malakowsky C, Choi J, Gracy R (2000) Oxidized proteins in Alzheimer's plasma. Biochem Biophys Res Commun 275:678-681
18. Costenbader KH, Karlson EW (2006) Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 15:737-745
19. Coti Bertrand P, O'Kusky J, Innis S (2006) Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J Nutr 136:1570-1575
20. Crews F, Nixon K (2009) Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol 44:115-127
21. Dai S, Zhou Y, Li W, An J, Li P, Yang N, Chen X, Xiong R, Liu P, Zhao Y, Shen H, Zhu P, Chen J (2010) Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury. J Neurosci 30:5802-5810
22. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I (2009) S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 1793:1008-1022
23. Donev R, Kolev M, Millet B, Thome J (2009) Neuronal death in Alzheimer's disease and therapeutic opportunities. J Cell Mol Med 13:4329-4348
24. Emmerling M, Watson M, Raby C, Spiegel K (2000) The role of complement in Alzheimer's disease pathology. Biochim Biophys Acta 1502:158-171
25. Encinas JM, Manganas L, Enikolopov G (2005) Nitric oxide and multiple sclerosis. Curr Neurol Neurosci Rep 5:232-238
26. Fenton W, Dickerson F, Boronow J, Hibbeln J, Knable M (2001) A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158: 2071-2074
27. Forsberg P, Martin S, Nilsson B, Ekman P, Nilsson U, Engström L (1990) In vitro phosphorylation of human complement factor C3 by protein kinase A and protein kinase C. Effects on the classical and alternative pathways. J Biol Chem 265:2941-2946
28. Fredriksson A, Archer T (2004) Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotox Res 6:435-456
29. García-Nogales P, Almeida A, Bolaños J (2003) Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection. J Biol Chem 278:864-874
30. Gershov D, Kim S, Brot N, Elkon K (2000) C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192:1353-1364
31. Grossfield A, Feller S, Pitman M (2006) A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc Natl Acad Sci USA 103:4888-4893
32. Hakobyan S, Harris C, van den Berg C, Fernandez-Alonso M, de Jorge E, de Cordoba S, Rivas G, Mangione P, Pepys M, Morgan B (2008) Complement factor H binds to denatured rather than to native pentameric C-reactive protein. J Biol Chem 283:30451-30460
33. Harper C (1998) The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 57:101-110
34. Harper C, Matsumoto I (2005) Ethanol and brain damage. Curr Opin Pharmacol 5:73-78
35. Hill D, D'Souza N, Lee E, Burikhanov R, Deaciuc I, de Villiers W (2002) A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 26:74-82
36. Hofmann M, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath M, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt A (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901
37. Hope B, Nagarkar D, Leonard S, Wise R (2007) Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers. J Neurosci 27:1964-1972
38. Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann H, Waisman A, Kuhlmann C (2010) Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 24:1023-1034
39. Jonakait G (2007) The effects of maternal inflammation on neuronal development: possible mechanisms. Int J Dev Neurosci 25:415-425
40. Kapoor R, Davies M, Blaker PA, Hall SM, Smith KJ (2003) Blockers of sodium and calcium entry protect axons from nitric oxidemediated degeneration. Ann Neurol 53:174-180
41. Kaur C, Ling E (2008) Antioxidants and neuroprotection in the adult and developing central nervous system. Curr Med Chem 15:3068-3080
42. Kawakita E, Hashimoto M, Shido O (2006) Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139:991-997
43. Kholodenko R, Kholodenko I, Sorokin V, Tolmazova A, Sazonova O, Buzdin A (2007) Anti-apoptotic effect of retinoic acid on retinal progenitor cells mediated by a protein kinase A-dependent mechanism. Cell Res 17:151-162
44. King V, Huang W, Dyall S, Curran O, Priestley J, Michael-Titus A (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 26:4672-4680
45. Kolev M, Ruseva M, Harris C, Morgan B, Donev R (2009) Implication of complement system and its regulators in Alzheimer's disease. Curr Neuropharmacol 7:1-8
46. Kolev M, Tediose T, Sivasankar B, Harris C, Thome J, Morgan B, Donev R (2010) Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration. Pharmacogenomics J 10:12-19
47. Kostrzewa R, Kostrzewa J, Kostrzewa R, Nowak P, Brus R (2008) Pharmacological models of ADHD. J Neural Transm 115:287-298
48. Lagace D, Noonan M, Eisch A (2007) Hippocampal neurogenesis: a matter of survival. Am J Psychiatry 164:205
49. Lasky-Su J, Neale B, Franke B, Anney R, Zhou K, Maller J, Vasquez A, Chen W, Asherson P, Buitelaar J, Banaschewski T, Ebstein R, Gill M, Miranda A, Mulas F, Oades R, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen H, Taylor E, Daly M, Laird N, Lange C, Faraone S (2008) Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 147B:1345-1354
50. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Deviere J (1995) Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology 22:1436-1439
51. Lemmers A, Moreno C, Gustot T, Maréchal R, Degré D, Demetter P, de Nadai P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O, Deviere J (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49:646-657
52. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237:1154-1162
53. Linnet K, Dalsgaard S, Obel C, Wisborg K, Henriksen T, Rodriguez A, Kotimaa A, Moilanen I, Thomsen P, Olsen J, Jarvelin M (2003) Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 160:1028-1040
54. Liu JS, Zhao ML, Brosnan CF, Lee SC (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 158:2057-2066
55. Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, Weksler B, De Caterina R (2006) The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA 103:15184-15189
56. McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, Grimshaw K, Kitchin E, Lok K, Porteous L, Prince E, Sonuga-Barke E, Warner J, Stevenson J (2007) Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 370:1560-1567
57. McClain C, Cohen D (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349-351
58. McClain C, Hill D, Song Z, Chawla R, Watson W, Chen T, Barve S (2002) S-adenosylmethionine, cytokines, and alcoholic liver disease. Alcohol 27:185-192
59. Melis M, Camarini R, Ungless M, Bonci A (2002) Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. J Neurosci 22:2074-2082
60. Mick E, Biederman J, Faraone S, Sayer J, Kleinman S (2002) Casecontrol study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 41:378-385
61. Mill J, Richards S, Knight J, Curran S, Taylor E, Asherson P (2004) Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry 9:801-810
62. Miller VM, Lewis DA, Rud KS, Offord KP, Croghan IT, Hurt RD (1998) Plasma nitric oxide before and after smoking cessation with nicotine nasal spray. J Clin Pharmacol 38:22-27
63. Min S, Moon I, Ko R, Shin H (2001) Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers. Psychopharmacology (Berl) 159:83-88
64. Misener V, Schachar R, Ickowicz A, Malone M, Roberts W, Tannock R, Kennedy J, Pathare T, Barr C (2004) Replication test for association of the IL-1 receptor antagonist gene, IL1RN, with attention-deficit/hyperactivity disorder. Neuropsychobiology 50:231-234
65. Monje M, Toda H, Palmer T (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760-1765
66. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M (2006) The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 19:1437-1445
67. Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H, Yasu T, Saito M, Momomura S, Kawakami M (2008) C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase- 9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 196:129-135
68. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M (1997) Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol 79:1538-1541
69. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952
70. Osaka H, Mukherjee P, Aisen P, Pasinetti G (1999) Complementderived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem 73:303-311
71. Paine T, Neve R, Carlezon WJ (2009) Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase within the medial prefrontal cortex of rats. Neuropsychopharmacology 34:2143-2155
72. Pasinetti G (1996) Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol Aging 17:707-716
73. Qin L, He J, Hanes R, Pluzarev O, Hong J, Crews F (2008) Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation 5:10
74. Raz R, Gabis L (2009) Essential fatty acids and attention-deficithyperactivity disorder: a systematic review. Dev Med Child Neurol 51:580-592
75. Redford EJ, Kapoor R, Smith KJ (1997) Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120(Pt 12):2149-2157
76. Reif A, Rösler M, Freitag C, Schneider M, Eujen A, Kissling C, Wenzler D, Jacob C, Retz-Junginger P, Thome J, Lesch K, Retz W (2007) Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology 32:2375-2383
77. Reif A, Jacob C, Rujescu D, Herterich S, Lang S, Gutknecht L, Baehne C, Strobel A, Freitag C, Giegling I, Romanos M, Hartmann A, Rösler M, Renner T, Fallgatter A, Retz W, Ehlis A, Lesch K (2009) Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 66:41-50
78. Retz W, Reif A, Freitag C, Retz-Junginger P, Rösler M (2010) Association of a functional variant of neuronal nitric oxide synthase gene with self-reported impulsiveness, venturesomeness and empathy in male offenders. J Neural Transm 117:321-324
79. Rezaee F, Rellick S, Piedimonte G, Akers S, O'Leary H, Martin K, Craig M, Gibson L (2010) Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS One 5:e9690
80. Ribasés M, Hervás A, Ramos-Quiroga J, Bosch R, Bielsa A, Gastaminza X, Fernández-Anguiano M, Nogueira M, Gómez- Barros N, Valero S, Gratacos M, Estivill X, Casas M, Cormand B, Bayés M (2008) Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry 63: 935-945
81. Riediger N, Othman R, Suh M, Moghadasian M, (2009) A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109:668-679
82. Romanos M, Gerlach M, Warnke A, Schmitt J (2010) Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 64:269-273
83. Rushforth S, Allison C, Wonnacott S, Shoaib M (2010) Subtypeselective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span task. Neurosci Lett 471:114-118
84. Sarkar R, Gelabert HA, Mohiuddin KR, Thakor DK, Santibanez- Gallerani AS (1999) Effect of cigarette smoke on endothelial regeneration in vivo and nitric oxide levels. J Surg Res 82:43-47
85. Schlaepfer I, Clegg H, Corley R, Crowley T, Hewitt J, Hopfer C, Krauter K, Lessem J, Rhee S, Stallings M, Wehner J, Young S, Ehringer M (2007) The human protein kinase C gamma gene (PRKCG) as a susceptibility locus for behavioral disinhibition. Addict Biol 12:200-209
86. Schmitt J, Romanos M, Schmitt N, Meurer M, Kirch W (2009) Atopic eczema and attention-deficit/hyperactivity disorder in a populationbased sample of children and adolescents. JAMA 301:724-726
87. Schmitt J, Apfelbacher C, Chen C, Romanos M, Sausenthaler S, Koletzko S, Bauer C, Hoffmann U, Krämer U, Berdel D, von Berg A, Wichmann H, Heinrich J, Group GINIpS (2010) Infantonset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol 125:404-410
88. Segman R, Meltzer A, Gross-Tsur V, Kosov A, Frisch A, Inbar E, Darvasi A, Levy S, Goltser T, Weizman A, Galili-Weisstub E (2002) Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder. Mol Psychiatry 7:72-74
89. Sen J, Belli A (2007) S100B in neuropathologic states: the CRP of the brain? J Neurosci Res 85:1373-1380
90. Sharp S, McQuillin A, Gurling H (2009) Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 57:590-600
91. Shinawi M, Liu P, Kang S, Shen J, Belmont J, Scott D, Probst F, Craigen W, Graham B, Pursley A, Clark G, Lee J, Proud M, Stocco A, Rodriguez D, Kozel B, Sparagana S, Roeder E, McGrew S, Kurczynski T, Allison L, Amato S, Savage S, Patel A, Stankiewicz P, Beaudet A, Cheung S, Lupski J (2009) Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioral problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 47:332-341
92. Shiow L, Paris K, Akana M, Cyster J, Sorensen R, Puck J (2009) Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clin Immunol 131:24-30
93. Shohami E, Novikov M, Bass R, Yamin A, Gallily R (1994) Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab 14:615-619
94. Silva C, Rio M, Cruz C (1985) Local immunoglobulin synthesis and blood-brain barrier assessment in subacute sclerosing panencephalitis. Eur Neurol 24:128-133
95. Smith KJ, Kapoor R, Hall SM, Davies M (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470-476
96. Smith M, Moylan J, Smith J, Li W, Reid M (2007) IFN-gamma does not mimic the catabolic effects of TNF-alpha. Am J Physiol Cell Physiol 293:C1947-C1952
97. Spector R (1988) Fatty-acid transport through the blood-brain barrier. J Neurochem 50:639-643
98. Stillwell W, Shaikh S, Zerouga M, Siddiqui R, Wassall S (2005) Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 45:559-579
99. Tai C, Chen C, Lee H, Wang Y, Li T, Mersamm H, Ding S, Wang P (2009) Docosahexaenoic acid enhances hepatic serum amyloid A expression via protein kinase A-dependent mechanism. J Biol Chem 284:32239-32247
100. Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 42:177-185
101. Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, Rutter M, Harold G (2009) Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry 66:722-727
102. Tikka T, Fiebich B, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580-2588
103. Toga A, Thompson P, Sowell E (2006) Mapping brain maturation. Trends Neurosci 29:148-159
104. Vincent S (2010) Nitric oxide neurons and neurotransmission. Prog Neurobiol 90:246-255
105. Wan J, Fu A, Ip F, Ng H, Hugon J, Page G, Wang J, Lai K, Wu Z, Ip N (2010) Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease. J Neurosci 30:6873-6881
106. Wang H, Zakhari S, Jung M (2010) Alcohol, inflammation, and gutliver- brain interactions in tissue damage and disease development. World J Gastroenterol 16:1304-1313
107. Yan S, Ramasamy R, Naka Y, Schmidt A (2003) Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93:1159-1169
108. Yan T, McQuillin A, Thapar A, Asherson P, Hunt S, Stanford S, Gurling H (2010) NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD. J Psychopharmacol 24:27-38
109. Zhou JF, Yan XF, Guo FZ, Sun NY, Qian ZJ, Ding DY (2000) Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress. Biomed Environ Sci 13:44-55